Mitochondria-Targeting Aromatic-Cationic Peptides for Oxidative Damage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic approaches lack effective methods for preventing or treating oxidative damage and mitochondrial dysfunction, which are associated with various diseases and conditions.
Innovation Solution
Administration of aromatic-cationic peptides, which localize to mitochondria, improve mitochondrial integrity and function, reduce mitochondrial permeability transition, and enhance ATP synthesis, thereby addressing oxidative damage and mitochondrial dysfunction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapeutic approaches are used, then treatment of oxidative damage and mitochondrial dysfunction is attempted, but effective prevention or treatment methods are lacking
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of peptide compounds to create aromatic-cationic peptides with specific properties. The peptides contain aromatic amino acids (phenylalanine, tyrosine, tryptophan) and cationic amino acids (arginine, lysine) in specific arrangements, with controlled molecular weight (500-2000 Da) and charge density, to achieve optimal mitochondrial targeting and protective effects against oxidative damage and mitochondrial dysfunction
Solution Approach 2:
The aromatic-cationic peptides act as intermediary substances that mediate protection of mitochondrial function. The peptides localize to mitochondria and interact with mitochondrial membranes and proteins, serving as a protective intermediary that reduces oxidative damage and prevents mitochondrial permeability transition without directly addressing the underlying disease causes
2Reliability
If aromatic-cationic peptides are administered, then mitochondrial integrity and function are improved, but the complexity of the therapeutic compound increases
Solution Approach 1:
The patent applies segmentation by dividing the therapeutic function into specific modular components within the peptide structure. The peptides are composed of discrete functional segments: aromatic residues for membrane interaction, cationic residues for charge-based targeting, and controlled length segments (4-20 amino acids) that together achieve mitochondrial localization and protective function while maintaining manageable structural complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The aromatic-cationic peptides effectively reduce oxidative damage, inhibit mitochondrial permeability transition, and increase ATP synthesis, providing a therapeutic benefit in treating or preventing diseases related to mitochondrial dysfunction.
Implementation Method 1
the peptides localize to the mitochondria and improve the integrity and function of the organelle
Implementation Method 2
the peptides localize to the mitochondria and improve the integrity and function of the organelle
Implementation Method 3
reduces the level of oxidative damage to cells and tissues
Implementation Method 4
increases the rate of mitochondrial ATP synthesis
Data Source
AI summary
The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. For example, the peptides may be administered to subjects in need of a mitochondrial-targeted antioxidant.